Status:
COMPLETED
Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery
Lead Sponsor:
Seoul National University Hospital
Conditions:
Cesarean Section Complications
Hypotension
Eligibility:
FEMALE
19+ years
Phase:
NA
Brief Summary
Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial
Detailed Description
The aim of this study was to find out whether the incidence of hypotension during surgery can be reduced in the case of non-invasive, continuous blood pressure monitoring using the ClearSight System i...
Eligibility Criteria
Inclusion
- Adult mothers who are pregnant with single fetuses over 35 weeks gestational age undergoing planned cesarean delivery under spinal anesthesia
Exclusion
- Multiple fetal pregnancy
- Preexisting hypertension or pregnancy-induced hypertension
- Underlying heart disease
- Underlying cerebrovascular disease
- Known fetal anomaly
- Contraindicated in spinal anesthesia
- Any sign of onset of labor
- Body weight \<45 kg or body weight\> 90 kg
- Height \<145cm or height\> 180cm
- All other cases in which researchers determine to be inappropriate for this clinical trial
Key Trial Info
Start Date :
April 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2022
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT04752904
Start Date
April 27 2021
End Date
December 21 2022
Last Update
December 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080